Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vanda Pharmaceuticals
(NQ:
VNDA
)
6.110
+0.120 (+2.00%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 26, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Vanda Pharmaceuticals
< Previous
1
2
3
Next >
A Sea Change in Motion Sickness Therapy: Vanda Pharmaceuticals' Tradipitant Shows Promising Data in Real-world Test
May 25, 2023
Via
Benzinga
Court Favors Vanda In Case Against FDA Over Detail Disclosure Of Rejection Of Sleep Disorder Drug
March 29, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
February 24, 2023
On Friday, 135 companies reached new 52-week lows.
Via
Benzinga
Why Vanda Pharmaceuticals Stock Crawled Higher Today
February 09, 2023
A solid earnings beat drove the company's share price upward.
Via
The Motley Fool
Earnings Preview: Vanda Pharmaceuticals
February 07, 2023
Via
Benzinga
Vanda Pharma's Antipsychotic Shows Improved Severity In Bipolar Disorder
December 19, 2022
Via
Benzinga
Looking Into Vanda Pharmaceuticals's Return On Capital Employed
August 10, 2022
Via
Benzinga
Recap: Vanda Pharma Q2 Earnings
August 03, 2022
Vanda Pharma (NASDAQ:VNDA) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
May 04, 2023
On Thursday, 498 companies reached new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
December 16, 2022
During Friday's trading, 293 companies set new 52-week lows.
Via
Benzinga
JetBlue Airways, Pacira BioSciences And Some Other Big Stocks Moving Lower On Tuesday
December 13, 2022
U.S. stocks traded slightly higher, with the Nasdaq Composite gaining around 70 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 13, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
December 14, 2022
On Wednesday, 115 stocks hit new 52-week lows.
Via
Benzinga
Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
December 13, 2022
Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.
Via
Benzinga
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
August 03, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Earnings Scheduled For November 2, 2022
November 02, 2022
Companies Reporting Before The Bell • Nomura Holdings (NYSE:NMR) is likely to report earnings for its second quarter.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 06, 2022
Via
Benzinga
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study
May 05, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Earnings Scheduled For May 5, 2022
May 05, 2022
Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
Via
Benzinga
Earnings Outlook For Vanda Pharmaceuticals
May 04, 2022
Vanda Pharmaceuticals (NASDAQ:VNDA) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Vanda...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 25, 2022
February 25, 2022
Upgrades According to 86 Research, the prior rating for NetEase Inc (NASDAQ:NTES) was changed from Hold to Buy. For the fourth quarter, NetEase had an EPS of $1.56,...
Via
Benzinga
10 Biggest Price Target Changes For Friday
February 25, 2022
Daiwa Capital cut the price target on Tesla, Inc. (NASDAQ: TSLA) from $980 to $900. Tesla shares rose 1.3% to $811.13 in pre-market trading.
Via
Benzinga
93 Biggest Movers From Friday
February 28, 2022
Gainers Inspirato Incorporated (NASDAQ: ISPO) shares surged 50.5% to close at $54.90. Guardforce AI Co., Limited (NASDAQ: GFAI) jumped 45.4% to settle at $0.5979 on Friday. EF...
Via
Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (...
Via
Benzinga
Vanda Pharmaceuticals: Q4 Earnings Insights
February 23, 2022
Vanda Pharmaceuticals (NASDAQ:VNDA) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:00 PM. Here's what investors need to know about the announcement....
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 23, 2022
Gainers SCYNEXIS (NASDAQ:SCYX) shares inc...
Via
Benzinga
Earnings Scheduled For February 23, 2022
February 23, 2022
Companies Reporting Before The Bell • Sapiens Intl Corp (NASDAQ:SPNS) is likely to report earnings for its fourth quarter. • Plymouth Industrial REIT (NYSE:PLYM)...
Via
Benzinga
50 Biggest Movers From Friday
February 07, 2022
Also check out this: Executives Sell Over $45M Of 5 Stocks Losers Ra Medical Systems, Inc. (NYSE: RMED) shares dipped 48.8% to close at $0.3599 on Friday after the...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
February 04, 2022
Gainers Quidel (NASDAQ:QDEL) shares incre...
Via
Benzinga
Mid-Afternoon Market Update: Dow Turns Positive; Snap Shares Climb Following Upbeat Results
February 04, 2022
The Dow Jones turned higher later in the session on Friday following upbeat earnings from Amazon.com, Inc. (NASDAQ: AMZN) and strong payrolls report for January.
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.